CCM
ZBH icon

Catapult Capital Management’s Zimmer Biomet ZBH Stock Holding History

Catapult Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-8,718
Closed -$801K – 260
2014
Q1 		$801K Sell
8,718
-97,356
-92% -$8.97M 0.16% 130
2013
Q4 		$9.6M Buy
106,074
+10,097
+11% +$874K 2.29% 5
2013
Q3 		$7.65M Buy
95,977
+94,909
+8,887% +$7.47M 0.95% 30
2013
Q2 		$78K Buy
+1,068
New +$79.9K 0.03% 211

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
IIS
Ignis Investment Services Edinburgh, United Kingdom $29.9B AUM
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Catapult Capital Management's ZBH Position: Q2 2014 in Review

Catapult Capital Management sold out of Zimmer Biomet (ZBH) in Q2 2014, closing a stake of 8,718 shares — an estimated $801K sold.

Catapult Capital Management first reported a position in ZBH in Q2 2013 and held it in 4 quarters. The position peaked at $9.6M in Q4 2013. 707 funds tracked by Wall St. Rank hold ZBH as of Q2 2014.

  • Catapult Capital Management reported no remaining Zimmer Biomet position as of Q2 2014 after selling out during the quarter.
  • Catapult Capital Management sold 8,718 Zimmer Biomet shares in Q2 2014, an estimated $801K.
  • Catapult Capital Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 4 quarters.
  • Catapult Capital Management's Zimmer Biomet position peaked at $9.6M in Q4 2013.
  • 707 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2014.

Based on Catapult Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.